Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$0.79 USD
-0.05 (-5.75%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $0.81 +0.02 (2.92%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | 18.52% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.84 |
Next Year | -0.82 |
EPS (TTM) | -1.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 2.72M | 6.89M | 14.44M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.21 | -0.84 | -0.82 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.19 | -0.21 | -0.83 | -0.65 |
High Estimate | -0.19 | -0.21 | -0.83 | -0.65 |
Low Estimate | -0.19 | -0.21 | -0.84 | -0.99 |
Year ago EPS | -0.53 | -0.43 | -1.36 | -0.84 |
Year over Year Growth Est. | 64.15% | 51.16% | 38.24% | 1.79% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.21 | -0.84 | -0.82 |
7 Days Ago | -0.19 | -0.21 | -0.84 | -0.82 |
30 Days Ago | -0.19 | -0.21 | -0.84 | -0.82 |
60 Days Ago | -0.27 | -0.26 | -1.04 | -1.07 |
90 Days Ago | -0.39 | -0.37 | -0.97 | -1.02 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.21 | -0.84 | -0.82 |
Zacks Consensus Estimate | -0.19 | -0.21 | -0.84 | -0.82 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.41 | -0.43 | -0.53 | NA |
Estimate | -0.27 | -0.48 | -0.50 | -0.49 | NA |
Difference | 0.05 | 0.07 | 0.07 | -0.04 | 0.04 |
Surprise | 18.52% | 14.58% | 14.00% | -8.16% | 9.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more